MedTrace Logo

Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee

NCT03307668 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2017-10-12

No results posted yet for this study

Summary

The purpose of this trial is to investigate the safety and effect of CaReS-1S to repair knee cartilage defects.

Conditions

  • Cartilage Defects

Interventions

DEVICE

CaReSR-1S

CaReSR-1S is a sterile, ready for use round implant based on a dense matrix of native Collagen type I.

DEVICE

Microfracture

Microfracture is an articular cartilage repair surgical technique that works by creating tiny fractures in the underlying bone. This causes new cartilage to develop from a so-called super-clot.

Sponsors & Collaborators

  • Arthro-Anda Tianjin Biologic Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03307668 on ClinicalTrials.gov